Requiring certain 340B entities to report annually to the Kansas department of insurance on certain costs, savings and payments made under the federal 340B drug pricing program.

HB 2550 requires Kansas hospitals participating in the federal 340B drug pricing program to submit annual reports starting January 1, 2027, to the Kansas Department of Insurance. The reports must detail how hospitals use 340B savings for community services, compare drug acquisition costs under 340B to other pricing sources, and provide specific financial data on drug expenditures, payments to pharmacies, and program administration. The Department of Insurance must publish these reports publicly on its website. This bill applies directly to Kansas hospitals designated as 340B entities under federal law, aiming to increase transparency around how these savings are utilized.